We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$1.05B
AUM Growth
+$101M
Cap. Flow
+$43.1M
Cap. Flow %
4.1%
Top 10 Hldgs %
42.07%
Holding
771
New
70
Increased
261
Reduced
141
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 7.68%
2 Healthcare 5.32%
3 Financials 3.58%
4 Consumer Discretionary 3.1%
5 Industrials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
726
Liberty Media Series A
FWONA
$23.6B
$1K ﹤0.01%
25
HPE icon
727
Hewlett Packard
HPE
$70.5B
$1K ﹤0.01%
131
+2
+2% +$19
LFVN icon
728
LifeVantage
LFVN
$85.3M
$1K ﹤0.01%
103
MANH icon
729
Manhattan Associates
MANH
$11.4B
$1K ﹤0.01%
12
MTNB icon
730
Matinas BioPharma
MTNB
$1.81M
$1K ﹤0.01%
25
MU icon
731
Micron Technology
MU
$991B
$1K ﹤0.01%
20
REZI icon
732
Resideo Technologies
REZI
$3.95B
$1K ﹤0.01%
+134
New +$1.7K
RMR icon
733
The RMR Group
RMR
$332M
$1K ﹤0.01%
28
+1
+4% +$29
SYF icon
734
Synchrony
SYF
$25.6B
$1K ﹤0.01%
32
TER icon
735
Teradyne
TER
$59.3B
$1K ﹤0.01%
+11
New +$933
UA icon
736
Under Armour Class C
UA
$2.53B
$1K ﹤0.01%
100
UAA icon
737
Under Armour
UAA
$2.6B
$1K ﹤0.01%
100
VBR icon
738
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$1K ﹤0.01%
11
-26
-70% -$2.91K
VFH icon
739
Vanguard Financials ETF
VFH
$13.8B
$1K ﹤0.01%
11
VKTX icon
740
Viking Therapeutics
VKTX
$4B
$1K ﹤0.01%
197
VSTM icon
741
Verastem
VSTM
$610M
$1K ﹤0.01%
83
WCC
742
WESCO International
WCC
$17.7B
$1K ﹤0.01%
+14
New +$598
XLF icon
743
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$1K ﹤0.01%
59
XRAY icon
744
Dentsply Sirona
XRAY
$2.43B
$1K ﹤0.01%
29
LGF.B
745
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1K ﹤0.01%
+69
New +$551
MRO
746
DELISTED
Marathon Oil Corporation
MRO
$1K ﹤0.01%
+200
New +$1.06K
HCDI
747
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$1K ﹤0.01%
+10
New +$1.15K
CLDR
748
DELISTED
Cloudera, Inc.
CLDR
$1K ﹤0.01%
82
APHA
749
DELISTED
Aphria Inc. Common Shares
APHA
$1K ﹤0.01%
150
BMY.RT
750
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
401
+1
+0.3% +$3

Similar funds

Capital Analysts LLC's Q3 2020 Portfolio in Review

As of Q3 2020, Capital Analysts LLC held 771 positions worth $1.05B, up 11% from $952M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Capital Analysts LLC deployed $43.1M of net new capital in Q3 2020, opening 70 new positions and adding to 261 existing holdings. Its largest new stake was Fiserv Inc: 14,288 shares worth $1.47M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Chubb, an estimated $2.41M trimmed.

  • Capital Analysts LLC's largest Q3 2020 buy was Fiserv Inc: 14,288 shares worth $1.47M.
  • Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q3 2020, an estimated $6.91M increase.
  • Capital Analysts LLC's biggest Q3 2020 reduction was Chubb, cutting an estimated $2.41M.
  • Capital Analysts LLC fully exited State Street SPDR S&P Biotech ETF in Q3 2020, selling an estimated $168K.
  • Capital Analysts LLC's ten largest holdings make up 42% of its $1.05B portfolio in Q3 2020.
  • Capital Analysts LLC opened 70 new positions and closed 14 in Q3 2020.
  • Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $1.05B.

Based on Capital Analysts LLC's 13F filing for Q3 2020, filed 12 Nov 2020.